drugset / Trial / NCT01678235

Insulin Glulisine and Aspart in Postprandial Glycemic Control After High-GI Meal in Children With Type 1 Diabetes Mellitus

NCT01678235

Phase 4 Completed 64 enrolled Medical University of Warsaw
RandomizedCrossoverQuadruple-blindTreatment

Summary

The aim of this study is to determine whether insulin glulisine is more effective in postprandial glycemic control than insulin aspart after the H-GI meal in children with type 1 diabetes (T1DM) treated with insulin pump (CSII).

Timeline

Start
2011-09
Primary completion
2012-09
Completion
2012-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin glulisine Protein / enzyme biologic
Subject insulin aspart Protein / enzyme biologic